版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
NephroticSyndromeOverviewDefinitionnephroticsyndromePathologyofprimarynephroticsyndromeandclinicalfeaturesDiagnosisandDifferentialdiagnosisComplicationsTreatmentofprimarynephroticsyndromeSecondarynephroticsyndrome-Diabeticnephropathy-Lupusnephritis-RenalAmyloidosis-HBV-associatednephropathy
ThemostcommonsyndromeofkidneydiseaseAcuteNephriticsyndromeNephroticsyndromeAsymptomaticurinaryabnormalitiesAcuterenalfailureorRapidlyprogressiverenalfailureChronickidneydisease(Table1)
(一)急性肾炎综合征(二)肾病综合征(三)无症状性尿检异常(四)急性及急进性肾衰竭综合征(五)慢性肾脏病(表1)2012KDIGO指南更新再强调:
蛋白尿水平及GFR是评估CKD进展的重要指标图注:绿色:低风险(如没有其他肾脏疾病的标志物);黄色:中度增加风险;桔色:高风险;红色:非常高风险持续性蛋白尿诊断标准和范围Kidneyinter.,Suppl.2012;2:337–414.
Pathophysiology:ProteinuriaFigure3.
lessthan150mg/24
hoursInnormalconditionalittleproteincanbeavailableinurineThreemainmechanismofproteinuriaGlomerular(increasefiltration)Tubular(decreasereabsorption)Overflow(markedoverproduction ofaparticularproteinNephroticSyndromeItisnotadiseasebutagroupofsignsandsymptomspresentswithedemaproteinuriausually>3.5g/24hrsserumalbumin<30g/Lotherfeatures:hyperlipidaemia,andhypercoaguablestatePathophysiologyPathologyofPrimaryNephtoticSyndromeMinimalChangeDiseaseMesanginalProliferativeGlomerulonephritisFocalSegmentalGlomerulosclerosisMembranousNephropathyMembranoproliferativeGlomerulonephritis(MPGN)NormalglomerulusLightmicrographofanormalglomerulus.Thereareonly1or2cellspercapillarytuft,thecapillarylumensareopen,thethicknessoftheglomerularcapillarywall(longarrow)issimilartothatofthetubularbasementmembranes(shortarrow),andthemesangialcellsandmesangialmatrixarelocatedinthecentralorstalkregionsofthetuft(arrows).CourtesyofHelmutGRennke.
Lightmicrographofanessentiallynormalglomerulusinminimalchangedisease.Thereareonly1or2cellspercapillarytuft,thecapillarylumensareopen,thethicknessoftheglomerularcapillarywallsisnormal,andthereisneitherexpansionnorhypercellularityinthemesangialareasinthecentralorstalkregionsofthetuft(arrows).CourtesyofHelmutGRennke.
MinimalchangediseaseMinimalchangediseaseMinimalchangediseaseElectronmicrographofanormalglomerularcapillaryloopshowingthefenestratedendothelialcell(Endo),theglomerularbasementmembrane(GBM),andtheepithelialcellswithitsinterdigitatingfootprocesses(arrow).TheGBMisthinandnoelectrondensedepositsarepresent.Twonormalplateletsareseeninthecapillarylumen.CourtesyofHelmutRennke,MD.
NormalglomerulusElectronmicrographinminimalchangediseaseshowinganormalglomerularbasementmembrane(GBM),noimmunedeposits,andthecharacteristicwidespreadfusionoftheepithelialcellfootprocesses(arrows).CourtesyofHelmutRennke,MD.
MinimalchangediseaseMinimalChangeDiseaseMostfrequentcauseofnephroticsyndromeinchildren.generalizededemawithnormalrenalfunctionandselectiveproteinuria.Hematuriaisabsentandpatientsarenormotensive.LM-Normal.IF-Negative.EM-footprocessfusion.Respondsreadilytosteroids,althoughrelapsesarecommon.Thelongtermprognosisisexcellent.SteroidresistantpatientsmayprogresstoFSGS.
FocalSegmentalGlomerulosclerosis
Occursinchildrenandadults,representingabout10%ofallcasesofnephroticsyndrome.Hematuria,hypertension,andnonselectiveproteinuriamaybepresent.LM:focalsegmentalglomerularsclerosis(hyalinosis)isseen.IF:IgMandC3inthesescleroticareas.Oftenpoorlyresponsivetosteroids.Childrenmayrespondmorefavorablythanadults.
Figure6.Lightmicroscopicappearancesinfocalsegmentalglomerulosclerosis.Segmentalscarswithcapsularadhesionsinotherwisenormalglomeruli.
MembranousnephropathyMostcommoncauseinadults.Especiallyelderlypeople.LM:glomerularbasementmembranethickeningwithnocellularproliferation.IF:granulardepositsofIgGandC3alongthebasementmembrane.EM:thickeningofbasementmembraneandfootprocessfusion.Theprognosisisvariable.Spontaneousremissionsoccurinsomecaseswhereasothersprogressslowlytochronicrenalfailure.Steroidsandimmunesuppressiveagentsmaybeeffectiveinretardingtheprogressiontorenalfailure.
ImmunofluorescencemicroscopyofMN(IgG)MembranousnephropathyLightmicrographofmembranousnephropathy,showingdiffusethickeningoftheglomerularbasementmembrane(longarrows)withessentiallynormalcellularity.Notehowthethicknessoftheglomerularcapillarywallsismuchgreaterthanthatoftheadjacenttubularbasementmembranes(shortarrow).Therearealsoareasofmesangialexpansion(asterisks).Immunofluorescencemicroscopy(showinggranularIgGdeposition)andelectronmicroscopy(showingsubepithelialdeposits)aregenerallyrequiredtoconfirmthediagnosis.CourtesyofHelmutRennke,MD.
ElectronmicrograpsshowsstageIImembranousnephropathy.Electrondensedeposits(D)arepresentinthesubepithelialspaceacrosstheglomerularbasementmembrane(GBM)andundertheepithelialcells(Ep).Newbasementmembraneisgrowingbetweenthedeposits,leadingtoaspikeappearanceonsilverstain.CourtesyofHelmutRennke,MD.
MembranousnephropathyComplicationsInfectionCoagulationdisordersAcuterenalfailureProteinmalnutritionanddyslipidemiaTheimpairmentofnormaldefenseisnotwellunderstood;
LowlevelsofimmunoglobulinGInfectionPatientswiththenephroticsyndromearesusceptibletoinfection,whichwastheleadingcauseofdeathinchildrenwiththenephroticsyndromebeforeantibioticsbecameavailable.Pneumococcalinfections,especiallyperitonitis,wereparticularlycommonComplicationsdecreasedlevelsofantithrombin
,plasminogen(urinarylosses),
hyperfibrinogenemiaincreasedplateletactivation
10to40percentofpatientsdevelopvenousthromboemboli,particularlydeepveinandrenalveinthrombosis
Renalveinthrombosiscanpresentacutelyor,muchmorecommonly,inanindolentmanner.
Theacutepresentationincludesflankpain,grosshematuria,andadeclineinrenalfunction..
Thromboembolism
Hypercoagulability
Hypovolemia
InterstitialedemaRenalperfusion↓ObstructionoftubularlumenRenalveinthrombosisNonsteroidalantiinflammatorydrugsAndotherdrugsPre-renalRenalfailureAcuteRenalFailurehypoalbuminemia,MalnutritionRetardationnegativenitrogenbalancehyperlipidemiaUrinarylossofhormones:vitamineD,T3andT4Edemaofthegastrointestinaltract:anorexiaandvomitInfectionImmunoglobin↓↓ThrombosisandemboliCardiovasculardiseaseeventsacceleratedatherosclerosisProteinmalnutrition
AmyloidosisLupusnephritisDiabeticnephropathyNephroticsyndromeassociatedmalignanceDifferentialDiagnosisRestDietary:sodiumandwaterrestriction(approximately3g/day)DiureticsLowerintraglomerularpressureStatintherapydonotrecommendroutineprophylacticanticoagulation.Generaltherapy(Nonimmunosuppressivetherapies
)TreatmentImmunosuppressivetherapyTreatmentGlucocorticoidsOtherimmunosuppressiveagents
—
Cyclophosphamide
orcyclosporineA
aloneorincombinationwithprednisonforrelapsing,glucocorticoid-dependentdiseaseorglucocorticoid-resistdisease.Dailyoralprednisone
(1mg/kgperdaytoamaximumof80mg/day)Asingledoseuponawakening(usuallybetweesevenandnineAM)Someclinicianspreferalternate-dayprednisonefromthebeginningtominimizethetoxicityoflong-termdailyprednisone,ataninitialdoseof2mg/kgeveryotherday(toamaximumdoseof120mg)Minimumofeightweeks,maximumduration
is16weeksSlowtaperingisperformedbothtosustaintheremissionandtoavoidadrenalsuppressionGlucocorticoidtherapyResponsetoGlucocorticoidtherapy
Acompleteremissionisareductioninproteinuriato300mg/day.Apartialresponseisareductioninproteinuriaof50percent,withabsolutevaluesbetween300mgand3.5g/day.Arelapseisreturnofproteinuriatoapproximately3.5gm/dayinpatientswhohadpreviouslyundergoneacompleteorpartialremission.Glucocorticoid-dependencereferstorelapsewhilerequirementforcontinuationofsteroidstomaintainremissionGlucocorticoid-resistancereferstolittleornoreductioninproteinuriaafter16weeksofadequateprednisone
therapy.Infectiousdisease:HeightenedriskoftypicalinfectionsOpportunisticinfections:HerpeszosterEndocrine:DiabetesmellitusBone:Osteoporosis
Gastrointestinal:Pepticulcerdisease,Pancreatitis,UGBEye:Elevatedintraocularpressure/glaucoma,ExophthalmosCardiovascular:HypertensionDermatologicandsofttissue:Skinthinningandpurpura,Cushingappearance,Acne.Majorsideeffectsassociatedwithcorticosteroidtherapy
Cyclophosphamide(CTX)
Azathioprine
(AZA)
Cyclosporine
(CysA)
Mycophenolate(MMF)
Tacrolimus(FK506)ImmunosuppressiveagentsNotthefirstchoiseanddon’tusealoneFrequentlyrelapsing,glucocorticoid-dependentorglucocorticoid-resistcasesImmunosuppressiveagentsA12-weekcourseof2mg/kgperdayofcyclophosphamide
Cumulativedoseof168mg/kgNeutropeniaandinfection—BonemarrowsuppressionGonadaltoxicity—atotaldosegreaterthan200to300mg/kgforCTX,Malignancy—acutelymphoblasticleukemia.AlopeciaandhemorrhagiccystitisLiverfunctioninjury.Otherscyclophosphamide-mostcommonlyuse
AlkylatingagentsCyclosporineatadoseof3to5mg/kgperdaytomaintainwholebloodtroughlevelsof100to200µg/LatleastsixmonthsCyclosporinesolutioncanbemixedwithmilk,chocolatemilk,ororangejuice(butnotgrapefruitjuice)atroomtemperature.Tacrolimusis0.05mg/kgperdaytomaintainwholebloodtroughlevelsbetween3and5µg/L.Thedosemaybeincreasedtoachieveahighertroughlevelbetween5and8µg/L,ifthereisnoreductioninproteinuriabytwomonths,providingtherenalfunctionhasnotworsened.
DOSAGEANDADMINISTRATIONCalcineurininhibitorsNephrotoxicity
—Hypertension
—
causedbyrenalvasoconstrictionandsodiumretention,Neurotoxicity—
severeheadache,visualabnormalities,andseizuresMetabolicabnormalities
—
GlucoseintoleranceInfections
—
Bacterial,viralandfungalinfectionsRiskofmalignancy
Othersideeffects
—
Gastrointestinalsideeffectsincludeanorexia,nausea,vomiting,diarrheaandabdominaldiscomfort
AdverseeffectassociatewithCalcineurininhibitorsThetargetdosageofMMFisgenerallybetween1.5to2gramsdaily.Startingwithlowerdosesatfirst(eg,500mgdailyforseveraldays)mayimprovepatients'gastrointestinaltoleranceofMMFAdverseeffect:Bonemarrowsuppression:cytopenias,requireregularmonitoringGastrointestinal
—
nearly75percentinitiallyhadgastrointestinal(GI)symptoms,includingnausea,diarrhea,andabdominalcramping.ThesesymptomsweretoleratedbetterwithtimeMycophenolatemofetil:
(MMF)
Treatedwithheparin
followedbywarfarinThegoalINRis1.5to2.0Durationofanticoagulation
—
Warfarin
therapyisgivenforaminimumof6to12months.Aslongasthepatientremainsnephrotic.Serumalbuminbelow2.0g/dL(20g/L)OptimaltherapyofhypercoagulabilityLotension,Losartan,Vasartan
,etclowerintraglomerularpressure,reductioninproteinexcretion,slowtherateofdiseaseprogression.Itisnotdependanttotheantihypertensiveeffect.Itispositivelyrelatedtothedoseofdrug.ACEI
and
ARBAcuterenalfailureHyperkalemiaNotices:Hypovolummia,useNSAIDtogetherSideeffectsPathologyIncidenceInfectionHematuriaHypertensionRenalinjuryTreatmentPrognosisMCDchildren(75%)commonlyseen---90%steroidsgoodFSGS5-15%younger+(65%)+(30%)+(10%)1/3
sensitive,dependentandresistrespectively
about10yearstoESRDMsPGN30%youngerandadult+++normalsomesensitive,somenotaccordingpathologyMembranousGNelderlyrarerareSteroid+cytotoxic1/4spontaneousremissions,progressslowlyMPGNyounger+grosshematuria+++(25%)resistpoorClinicalFeaturesandPathologyofPrimaryNephroticSyndrome20percentofcasesofsteroid-resistantNSareduetomutationsoftheNPHS1,NPHS2,WT1gene.Inpatientswithsteroid-resistantNSduetogenemutation,
wedonotrecommendimmunosuppressivetherapyOptimaltreatmentofSRNSnotduetoageneticdisorderis
unknown,Acombinationofcyclosporine
andprednisoneisrecommended,.Alternatively,cyclophosphamide,andtacrolimus
havealsobeenused.Hotpoints1:AboutFSGSSecondaryGlomerularDisease–-SecondarynephroticsyndromeWhytalkaboutdiabeticnephropathy?MostcommonsinglecauseESRDintheUS,Europe,andJapan17milliondiabeticsintheUS20-30%diabetics(bothtypeIandtypeII)developdiabeticnephropathy40%ESRDinUSrelatedtodiabeticnephropathyDefinitionAmicrovascularcomplicationofdiabetesmarkedbyalbuminuria,elevatedbloodpressure,andadeterioratingcoursefromnormalrenalfunctiontoESRD.ClinicalfeaturesGraduallyprogressiveproteinuriaMicroalbuminuriaisfirstclueBlandurinesediment–noRBCs,casts,etcGraduallydecreasingGFRPatientsasymptomatic,butdevelopworseninghypertensionNature
courseClinicalStagesofDN(Type1)1ststage:Renalenlargementandhyperfiltration2ndstage:Reversemicroalbuminuria,UAEisnormal(5-15).3rdstage:Microalbuminuria,incipientnephropathy(6-15Y)20-199ug/min30-299mg/24hcollection4thstage:Macroalbuminuria,overtnephropathy(10-15Y)>200ug/min>300mg/24hcollection5thstage:Progressiverenalfailureandsevereproteinuria(15-25Y)HowtodistinguishfromanotherkidneydiseaseLikelydiabetes:MacroalbuminuriaMicroalbuminuria,andPresenceofdiabeticretinopathyType1diabetesforatleast10yearsNoactiveurinarysedimentLikelyanothercauseofCKD:AbsenceofretinopathyRapidlydecreasingGFRhematuriaRefractoryhypertensionSignsorsxofothersystemicdiseaseTreatmentEarlyscreening TightglycemiccontrolHTNmanagementUseACEIasfirstline,ifnottolerated,useARB.UsethemaximumdoseastoleratedLupusnephritisSystemiclupuserythematosus(SLE)isamultisystem,autoimmuneds.withantibodiesdirectedagainstawidevarietyofcellularcomponentsLupusnephritisisoneofthemostseriousmanifestationsof(SLE).Frequency,race,sexandage
TheprevalenceofSLEis1caseper2000inthegeneralpopulation.SLEismorecommoninblackpeople,HispanicpeopleandAsianthaninwhitepeople.lupusnephritismorecommoninfemalesandtypicallyoccursinpatientsaged20-40years;clinicalrenaldiseasewithaworseprognosisismorecommoninmaleswithSLE.
ClinicalfeaturesVariousorgansystemsareeffected,likeskin,joints,serousmembranes,heart,neurologic,bloodandthekidneys.Rash,oralornasalulcers,synovitis,fatigue,fever,arthritis,serositis,edema,etc.ClinicalsignsLaboratoryStudiesTestsofSLEdiseaseactivityDiseaseactivity:ANA,anti-dsDNA,C3,C4,andCH50
,ESRorCRP.Creatine,urea,urialysisRenalbiopsyisusefulindeterminingprognosisandtreatment.IF:Fullhouse.LupusNephritisStageFeaturesStageINormallookingglomeruliStageIIMesangialexpansionStageIIIFocalproliferative<50%StageIVDiffuseProlif.>50%stageVMembranousStageVIAdv.sclerosinglesionsPathologyoflupusnephritisTreatmentLupusnephritiscantransformfromoneclasstotheotheroverthecourseofthedisease.CorticosteroidtherapyshouldbeinstitutedClassIV(themostaggressiveform)isusuallytreatedwithsteroidsandcyclophosphamide.OtherimmunosuppressantlikeMMF,cyclosporinehasbeenusedinthesecases.Treathypertensionaggressively.Preventosteoporosisetc.AmyloidosisAmyloidosisisaclinicaldisordercausedbyextracellulardepositionofinsolubleabnormalfibrilsthatinjuretissue.AmyloidosisALamyloid(primaryamyloid)associatedwithplasmacelldisorders,mostlyovertmyelomaAAamyloid(secondaryamyloid)isanacutephasereactantassociatedwithchronicinflammatorydiseasesliketuberculosis,osteomyelitis,rheumatoidarthritisandbronchiectasisMorecommoninelderlyTheamyloidisaneosinophilicextracellularsubstance,Congoredstainpositiveandblue-greenbirefringence.AmyloidosisArangeofclinicalpresentationswithrenal,heart,gastrointestine,localdepositionandotherproblemsRenalfailureandnephroticrangeproteinuriaarethemostcommonrenalpresentationAbnormalelevatingofMonoclonalIginbloodandlightchains(BenceJones)inurineinALamyloid.Relatedrenaldisordersincludelightchaindepositdisease,fibrillaryGNandimmunotactoidGNPrognosisforispoor.MonoclonalpatternSPEPUrinarymonoclonalproteinPanelB:Adense,localizedband(redasterisk)representingamonoclonalproteinofgammamobilityisseenonserumproteinelectrophoresisonagarosegel(anodeonleft).PanelA:Densitometertracingofthesefindingsrevealsatall,narrow-basedpeak(redasterisk)ofgammamobilityandareductioninthenormalpolyclonalgammaband.Themonoclonalbandhasadensitometricappearancesimilartothatofalbumin(alb),andhasbeenlikenedtoachurchspire.PanelB:Thisfigureillustratesthecelluloseacetateelectrophoreticpatternofaurinesample.Itrevealsadensebandofproteinwithbetamobility.PanelA:Densitometertracingshowsatall,narrow-basedpeakofbetamobility.Thesefindingsareconsistentwithaurinemonoclonalprotein(BenceJonesprotein);NormalpatternofSPEPCLINICALMANIFESTATIONSRenaldisease
—
asymptomaticproteinuriaorclinicallyapparentnephroticsyndromeCardiomyopathy
—
systolicordiastolicdysfunctionandheartfailure.syncopeduetoarrhythmiaheartblock,andanginaorinfarctionduetoaccumulationofamyloidinthecoronaryarteries.Gastrointestinaldisease
—
Hepatomegalywithorwithoutsplenomegaly.Bleeding,gastroparesis,constipation,etc.Neurologicabnormalities
—
Mixedsensoryandmotorperipheralneuropathyand/orautonomicneuropathyMusculoskeletaldisease
—pseudohypertrophy,alargetongueHematologicabnormalities
—bleedingdiathesis,factorXdeficiencySkinmanifestations
—waxythickening,easybruising,andsubcutaneousnodulesorplaques.Purpura,inaperiorbitaldistribution(raccooneyes).Others:Pulmonary,visualabilityLightmicrographofglomerularamyloidosisshowsnodular,amorphousmaterial(arrows)extendingfromthemesangiumintothecapillaryloopsandnarrowingorclosingthecapillarylumens.ThenodulesaremoreamorphousthanthoseseenindiabeticnephropathybutdemonstrationofamyloidfibrilsonelectronmicroscopyordemonstratinggreenbirefringenceonCongoredstainingisrequiredtoconfirmthediagnosis.CourtesyofHelmutRennke,MD.
Congoredstainviewedunderpolarizedlightofarenalbiopsyfromapatientwithrenalamyloidosis.Greenbirefringence(whitearrows)ofinterstitialamyloiddepositscanbeseen.CourtesyofHelmutRennke,MD.
Electronmicrographshowingexpansionofthemesangiumbyamyoidfibrilsmeasuringbetween9and11nanometersindiameter.Thefibrillarappearanceisbestappreciatedatthearrow.Thesefibrilsaresmallerthanthoseseeninfibrillaryglomerulonephritis.CourtesyofHelmutRennke,MDRenaltubularamyloidosisAmyloidosiswithmarkeddepositioninthetubularbasementmembranesonlightmicroscopy(leftpanel,arrows).TheamyloiddepositsshowgreenbirefringencewhenviewedunderpolarizedlightwithCongoredstain(rightpanel).CourtesyofHelmutRennke,MD.OutcomeSurvivalfromonsetofsymptomsvariesfrom1moto10yr.Therateofdiseaseprogressionisvariableanddependsontheextentoforganinvolvement.Henoch-SchönleinpurpuranephritisHSPisasmall-vesselvasculitischaracterizedbypurpura,
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2024年小型工程机械项目策划方案报告
- 08.药品采购合同
- 北斗星花园小区园林景观设计合同(规范版本)
- 新产品代理合同书
- 关于口头合同若干问题的实务分析
- 领导力心得体会7篇
- 湖南省长沙市路口镇路口中学高一数学文下学期摸底试题含解析
- 辽宁省沈阳市黄家锡伯族学校高一数学文下学期摸底试题含解析
- 初中生实践总结及心得体会6篇
- 大病倡议书5篇
- 北京高考地理知识点复习
- 电子通信系统割接解决方案
- 大学英语教学指南
- 小学语文人教四年级下册(统编)(教研版)第七单元-边塞诗中的家国情怀教学设计
- 电商网红直播基地建设方案
- 档案室消防安全管理制度(精选10篇)
- 公路沥青路面施工技术规范
- 化学生活中趣味故事
- 高中数学一轮复习必备知识点-PPT课件(PPT 98页)
- XX省南师附中、天一中学、海安中学、海门中学2022届高三12月四校联考化学试题附参考答案
- 幼儿园呕吐物处理方案课件
评论
0/150
提交评论